241 related articles for article (PubMed ID: 34050706)
1. Clinical spectrum of individuals with de novo EBF3 variants or deletions.
Nishi E; Uehara T; Yanagi K; Hasegawa Y; Ueda K; Kaname T; Yamamoto T; Kosaki K; Okamoto N
Am J Med Genet A; 2021 Oct; 185(10):2913-2921. PubMed ID: 34050706
[TBL] [Abstract][Full Text] [Related]
2. De novo variants in
Tanaka AJ; Cho MT; Willaert R; Retterer K; Zarate YA; Bosanko K; Stefans V; Oishi K; Williamson A; Wilson GN; Basinger A; Barbaro-Dieber T; Ortega L; Sorrentino S; Gabriel MK; Anderson IJ; Sacoto MJG; Schnur RE; Chung WK
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162653
[TBL] [Abstract][Full Text] [Related]
3. Urologic manifestations of hypotonia, ataxia, and delayed development syndrome (HADDS), a rare neurodevelopmental disorder.
Batie SF; Ashbrook CQ; Coco CT; Baker LA; Stanasel I
J Pediatr Urol; 2023 Dec; 19(6):751.e1-751.e9. PubMed ID: 37718233
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of clinical features and EBF3 gene variant in a child with hypotonia, ataxia and developmental delay].
Cong Y; Wang D; Wang H; Xu X; Wu K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1270-1274. PubMed ID: 36317217
[TBL] [Abstract][Full Text] [Related]
5. Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism.
Padhi EM; Hayeck TJ; Cheng Z; Chatterjee S; Mannion BJ; Byrska-Bishop M; Willems M; Pinson L; Redon S; Benech C; Uguen K; Audebert-Bellanger S; Le Marechal C; Férec C; Efthymiou S; Rahman F; Maqbool S; Maroofian R; Houlden H; Musunuri R; Narzisi G; Abhyankar A; Hunter RD; Akiyama J; Fries LE; Ng JK; Mehinovic E; Stong N; Allen AS; Dickel DE; Bernier RA; Gorkin DU; Pennacchio LA; Zody MC; Turner TN
Hum Genomics; 2021 Jul; 15(1):44. PubMed ID: 34256850
[TBL] [Abstract][Full Text] [Related]
6. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
Chao HT; Davids M; Burke E; Pappas JG; Rosenfeld JA; McCarty AJ; Davis T; Wolfe L; Toro C; Tifft C; Xia F; Stong N; Johnson TK; Warr CG; ; Yamamoto S; Adams DR; Markello TC; Gahl WA; Bellen HJ; Wangler MF; Malicdan MCV
Am J Hum Genet; 2017 Jan; 100(1):128-137. PubMed ID: 28017372
[TBL] [Abstract][Full Text] [Related]
7. Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism.
Harms FL; Girisha KM; Hardigan AA; Kortüm F; Shukla A; Alawi M; Dalal A; Brady L; Tarnopolsky M; Bird LM; Ceulemans S; Bebin M; Bowling KM; Hiatt SM; Lose EJ; Primiano M; Chung WK; Juusola J; Akdemir ZC; Bainbridge M; Charng WL; Drummond-Borg M; Eldomery MK; El-Hattab AW; Saleh MAM; Bézieau S; Cogné B; Isidor B; Küry S; Lupski JR; Myers RM; Cooper GM; Kutsche K
Am J Hum Genet; 2017 Jan; 100(1):117-127. PubMed ID: 28017373
[TBL] [Abstract][Full Text] [Related]
8. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
9. Novel de novo variant in
Blackburn PR; Barnett SS; Zimmermann MT; Cousin MA; Kaiwar C; Pinto E Vairo F; Niu Z; Ferber MJ; Urrutia RA; Selcen D; Klee EW; Pichurin PN
Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001743. PubMed ID: 28487885
[TBL] [Abstract][Full Text] [Related]
10. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
[TBL] [Abstract][Full Text] [Related]
11. De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome.
Sleven H; Welsh SJ; Yu J; Churchill MEA; Wright CF; Henderson A; Horvath R; Rankin J; Vogt J; Magee A; McConnell V; Green A; King MD; Cox H; Armstrong L; Lehman A; Nelson TN; ; ; Williams J; Clouston P; Hagman J; Németh AH
Am J Hum Genet; 2017 Jan; 100(1):138-150. PubMed ID: 28017370
[TBL] [Abstract][Full Text] [Related]
12. Duplication/triplication mosaicism of EBF3 and expansion of the EBF3 neurodevelopmental disorder phenotype.
Ignatius E; Puosi R; Palomäki M; Forsbom N; Pohjanpelto M; Alitalo T; Anttonen AK; Avela K; Haataja L; Carroll CJ; Lönnqvist T; Isohanni P
Eur J Paediatr Neurol; 2022 Mar; 37():1-7. PubMed ID: 34999443
[TBL] [Abstract][Full Text] [Related]
13. A Novel
Huang Y; Mei L; Wang Y; Ye H; Ma X; Zhang J; Cai M; Li P; Ge Y; Zhou Y
Front Genet; 2021; 12():676832. PubMed ID: 34367240
[TBL] [Abstract][Full Text] [Related]
14. Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3.
Schirwani S; Albaba S; Carere DA; Guillen Sacoto MJ; Milan Zamora F; Si Y; Rabin R; Pappas J; Renaud DL; Hauser N; Reid E; Blanchet P; Foulds N; Dixit A; Fisher R; Armstrong R; Isidor B; Cogne B; Schrier Vergano S; Demirdas S; Dykzeul N; Cohen JS; Grand K; Morel D; Slavotinek A; Albassam HF; Naik S; Dean J; Ragge N; Costa C; Tedesco MG; Harrison RE; Bouman A; Palen E; Challman TD; Willemsen MH; Vogt J; Cunniff C; Bergstrom K; Walia JS; Bruel AL; Kini U; Alkuraya FS; Slegesky V; Meeks N; Girotto P; Johnson D; ; Newbury-Ecob R; Ockeloen CW; Prontera P; Lynch SA; Li D; Graham JM; Pierson TM; Balasubramanian M
Am J Med Genet A; 2021 Nov; 185(11):3446-3458. PubMed ID: 34436830
[TBL] [Abstract][Full Text] [Related]
15. Microdeletion and microduplication of 1p36.11p35.3 involving AHDC1 contribute to neurodevelopmental disorder.
Wang Q; Huang X; Liu Y; Peng Q; Zhang Y; Liu J; Yuan H
Eur J Med Genet; 2020 Jan; 63(1):103611. PubMed ID: 30615951
[TBL] [Abstract][Full Text] [Related]
16. De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability, neuromuscular and psychiatric symptoms.
Powis Z; Petrik I; Cohen JS; Escolar D; Burton J; van Ravenswaaij-Arts CMA; Sival DA; Stegmann APA; Kleefstra T; Pfundt R; Chikarmane R; Begtrup A; Huether R; Tang S; Shinde DN
Clin Genet; 2018 May; 93(5):1030-1038. PubMed ID: 29251763
[TBL] [Abstract][Full Text] [Related]
17. Whole Gene Deletion of
Lopes F; Soares G; Gonçalves-Rocha M; Pinto-Basto J; Maciel P
Front Genet; 2017; 8():143. PubMed ID: 29062322
[TBL] [Abstract][Full Text] [Related]
18. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
[TBL] [Abstract][Full Text] [Related]
19. Rare predicted deleterious FEZF2 variants are associated with a neurodevelopmental phenotype.
Garber A; Weingarten LS; Abreu NJ; Elloumi HZ; Haack T; Hildebrant C; Martínez-Gil N; Mathews J; Müller AJ; Valenzuela Palafoll I; Steigerwald C; Chung WK
Am J Med Genet A; 2024 Jul; 194(7):e63578. PubMed ID: 38425142
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
